ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 149 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $966,000 | -66.3% | 104,000 | -42.9% | 0.00% | -66.7% |
| Q4 2021 | $2,868,000 | -17.0% | 182,000 | -5.7% | 0.00% | -25.0% |
| Q3 2021 | $3,455,000 | +149.6% | 193,000 | +116.9% | 0.00% | +100.0% |
| Q2 2021 | $1,384,000 | +12.1% | 89,000 | +3.5% | 0.00% | 0.0% |
| Q1 2021 | $1,235,000 | -83.5% | 86,000 | -77.5% | 0.00% | -81.8% |
| Q4 2020 | $7,499,000 | -58.1% | 382,000 | -72.4% | 0.01% | -67.6% |
| Q3 2020 | $17,911,000 | -15.6% | 1,382,041 | -5.1% | 0.03% | -24.4% |
| Q2 2020 | $21,219,000 | +38.5% | 1,456,368 | -19.1% | 0.04% | +12.5% |
| Q1 2020 | $15,318,000 | -48.3% | 1,800,000 | 0.0% | 0.04% | -31.0% |
| Q4 2019 | $29,646,000 | +9684.2% | 1,800,000 | +8289.7% | 0.06% | +5700.0% |
| Q3 2019 | $303,000 | -61.1% | 21,455 | +9.5% | 0.00% | -50.0% |
| Q1 2019 | $779,000 | -88.3% | 19,600 | -89.8% | 0.00% | -86.7% |
| Q4 2018 | $6,673,000 | – | 192,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
| Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
| Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
| BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
| Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
| MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
| Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
| Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |